The data together indicate that HAI-2 exhibits a distinct regulation on its target serine protease in different cancers; e.g., the HAI-2/matriptase axis for prostate cancer11,39 versus the HAI-2/plasmin axis for NSCLC. Here, PLG is linked to cancer.